ICD within 90 days of revascularization

Jump to navigation Jump to search
ICD Guidelines
Microchapters

ICD Main Page

Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Implantable Cardioverter-Defibrillators

Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease

Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials

ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction

ICD Implantation Within 40 Days of a Myocardial Infarction

ICD Implantation Within 90 Days of Revascularization

ICD Implantation Less Than 9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]

ICD Implantation Within 90 Days Of Revascularization[1]

Recommended
"1. In patients within 90 days of revascularization who have previously qualified for the implantation of an ICD for secondary prevention of sudden cardiac death (resuscitated from cardiac arrest due to ventricular tachyarrhythmia) and have abnormal left ventricular function, implantation of an ICD is recommended."
"2. In patients within 90 days of revascularization who have previously qualified for the implantation of an ICD for secondary prevention of sudden cardiac death (resuscitated from cardiac arrest due to ventricular tachyarrhythmia) that is unlikely related to myocardial ischemia/injury and have normal left ventricular function, implantation of an ICD is recommended."
"3. In patients within 90 days of revascularization who require nonelective permanent pacing, who would also meet primary prevention criteria for implantation of an ICD, and in whom recovery of left ventricular function is uncertain or not expected, implantation of an ICD with appropriately selected pacing capabilities is recommended."
"4. In patients within 90 days of revascularization with structural heart disease and sustained (or hemo- dynamically significant) ventricular tachyarrhythmia that was not clearly related to acute myocardial infarction or ischemia, implantation of an ICD is recommended. "
"5. In patients within 90 days of revascularization with an ICD that requires replacement due to battery depletion, after careful assessment of comorbidities and the cur- rent clinical situation, replacement of the ICD generator is recommended."
Can be Useful

"1. In patients who are within 90 days of revascularization and who previously qualified for the implantation of an ICD for primary prevention of sudden cardiac death, and who have undergone revascularization that is unlikely to result in an improvement in LVEF >0.35, and who are not within 40 days after an acute MI, implantation of an ICD can be useful."

"2. In patients within 90 days of revascularization who have previously qualified for the implantation of an ICD for secondary prevention of sudden cardiac death (resuscitated from cardiac arrest due to ventricular tachyarrhythmia) that was not related to acute myo- cardial ischemia/injury and who were subsequently found to have coronary artery disease that is revascularized with normal left ventricular function, implantation of an ICD can be useful."

"3. In patients who, within 90 days of revascularization, develop sustained (or hemodynamically significant) VT that can be treated by ablation therapy, implantation of an ICD can be useful."

"4. In patients within 90 days of revascularization present with syncope that is thought to be due to ventricular tachyarrhythmia (by clinical history or documented NSVT, or EP study), implantation of an ICD can be useful."

"5. In patients within 90 days of revascularization who have been listed for heart transplant or implanted with a ventricular assist device, and who are not within 40 days of an acute myocardial infarction, implantation of an ICD can be useful."

  1. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L (2014). "HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials". J. Am. Coll. Cardiol. 64 (11): 1143–77. doi:10.1016/j.jacc.2014.04.008. PMID 24820349.